Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review.

A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol (2001) 1.27

High-resolution record of Northern Hemisphere climate extending into the last interglacial period. Nature (2004) 6.44

The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05

Serum levels of cytokines in chronic liver diseases. Gastroenterology (1992) 3.47

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31

A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol (2001) 2.79

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother (2007) 2.49

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract (1986) 2.19

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99

Assignment of fingerprint vibrations in the resonance Raman spectra of rhodopsin, isorhodopsin, and bathorhodopsin: implications for chromophore structure and environment. Biochemistry (1987) 1.81

Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leuk Res (2001) 1.75

T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A (1995) 1.71

Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1985) 1.71

Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res (2001) 1.66

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. Ann Oncol (2010) 1.64

Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62

Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol (1994) 1.62

Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients. Eur Urol (2005) 1.62

VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res (2000) 1.58

The structure and function of the regulatory elements of the Escherichia coli uvrB gene. Nucleic Acids Res (1981) 1.58

Chromophobe cell renal carcinoma and its variants--a report on 32 cases. J Pathol (1988) 1.57

The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunol (1981) 1.53

[Study of variations of the left ventricle diameter in man by using transthoracic echocardiography]. Arch Mal Coeur Vaiss (1969) 1.49

Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation (1983) 1.47

Sulphate transporter gene mutations in apparently isolated club foot. J Med Genet (2001) 1.47

Aniline blue staining as a marker of sperm chromatin defects associated with different semen characteristics discriminates between proven fertile and suspected infertile men. Int J Androl (1990) 1.46

[Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results]. Actas Urol Esp (2011) 1.46

The prevalence of chromosomal abnormalities in subgroups of infertile men. Hum Reprod (2011) 1.45

Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44

Further evidence for lymphokine overproduction in severe aplastic anemia. Blood (1988) 1.43

Effectiveness of intraocular lens calculation in high ametropia. J Cataract Refract Surg (1989) 1.42

Maintaining continuity of clinical operations while implementing large-scale filmless operations. J Digit Imaging (1999) 1.42

Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood (1996) 1.41

Epidural butorphanol does not reduce side effects from epidural morphine after cesarean birth. Anesth Analg (1994) 1.39

Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia (2002) 1.39

Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol (1992) 1.37

Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. J Exp Med (1982) 1.37

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother (2010) 1.36

Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol (1983) 1.34

Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst (1999) 1.33

Setting standards of quality in family planning programs. Stud Fam Plann (1993) 1.30

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun (2000) 1.29

Solid-state 13C and 15N NMR study of the low pH forms of bacteriorhodopsin. Biochemistry (1990) 1.28

State dependent dissociation of HERG channel inhibitors. Br J Pharmacol (2007) 1.27

Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res (2001) 1.25

Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer (1993) 1.25

Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study. Cancer (1994) 1.23

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J Exp Med (1998) 1.22

Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos (1998) 1.20

Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest (1987) 1.19

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation (1990) 1.18

Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res (1997) 1.18

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res (1998) 1.17

Liver transplantation followed by high-dose cyclophosphamide, total-body irradiation, and autologous bone marrow transplantation for treatment of metastatic breast cancer. A case report. Transplantation (1984) 1.16

[Fournier gangrene as a rare complication after stapler hemorrhoidectomy. Case report and review of the literature]. Chirurg (2001) 1.15

Structure of a promotor on plasmid pMB9 derived from plasmid pSC101. Nucleic Acids Res (1980) 1.15

Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem (1987) 1.15

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol (1995) 1.14

Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med (1990) 1.14

Elevated urinary neopterin levels in patients with the acquired immunodeficiency syndrome (AIDS). A preliminary report. Hoppe Seylers Z Physiol Chem (1983) 1.14

Analysis of the structure-function relationship of the S-layer protein SbsC of Bacillus stearothermophilus ATCC 12980 by producing truncated forms. Microbiology (2001) 1.14

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther (2010) 1.14

Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol (1993) 1.13

Morphological classification of renal cancer. World J Urol (1995) 1.13

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant (2005) 1.13

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. Br J Cancer (2003) 1.12

The chronology of third molar mineralization in the Austrian population--a contribution to forensic age estimation. Forensic Sci Int (2006) 1.11

Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol (2004) 1.11

Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res (1986) 1.11

Solid-state 13C NMR of the retinal chromophore in photointermediates of bacteriorhodopsin: characterization of two forms of M. Biochemistry (1989) 1.10

Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo. Cancer Res (1999) 1.10

The impact of the quality of family planning services on contraceptive use in Peru. Stud Fam Plann (1996) 1.09

Zinc deficiency and zinc repletion: effect on the response of rats to infection with Trichinella spiralis. Am J Clin Nutr (1990) 1.09

Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology (2011) 1.09

Planned myopic astigmatism as a substitute for accommodation in pseudophakia. J Am Intraocul Implant Soc (1981) 1.08

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur J Immunol (1998) 1.07

Cyclosporin blood levels do correlate with clinical complications. Lancet (1984) 1.07

Combined liver and kidney transplantation. Lancet (1984) 1.07

Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer (1993) 1.06

IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol (1988) 1.06

Rearrangements involving 12p12 in two cases of cardiac myxoma. Cancer Genet Cytogenet (1995) 1.06

Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol (1993) 1.06

Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol (2002) 1.06

Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop Med Int Health (1999) 1.05

Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest (1983) 1.04

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04

Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. Br J Haematol (1994) 1.03

Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplant (2006) 1.03

Isoalloxazine derivatives promote photocleavage of natural RNAs at G.U base pairs embedded within helices. Nucleic Acids Res (1997) 1.03

Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol (2005) 1.02